Cytori Therapeutics Inc (NASDAQ:CYTX) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Monday. According to Zacks, “Cytori Therapeutics, Inc. is …
Breeze2mon
Cytori Therapeutics (NSDQ:CYTX) said today that it priced an underwritten public offering of 8.6 million shares of common stock at $1.10 apiece. …
public offering
One stock that might be an intriguing choice for investors right now is Cytori Therapeutics, Inc. ( CYTX). This is because this security in the pharmaceutical space is seeing solid earnings estimate revision activity, and is in …
Cytori Therapeutics, Inc. (CYTX - Free Report) was a big mover last session, as its shares rose above 13% on the day. The upside might have been driven by the receipt of patents by the company in Japan and Europe which …
Cytori Therapeutics Inc
SAN DIEGO, April 10, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (“Cytori” or the “Company”) (NASDAQ:CYTX) announced today that it intends to offer and sell shares of its common stock in an …
Public Offering
Stock market analysts and brokers have recently amended their target prices on shares of Cytori Therapeutics Inc (CYTX). The most recent analyst ratings issued by brokerages: 02/15/2017 – Cytori Therapeutics Inc had its …
That said, ratings given to stock have a considerable impact on the price movements, and they provide individual shareholder a clue of comprehensive sentiment or course. Cytori Therapeutics Inc (NASDAQ:CYTX) rating …
Cytori Therapeutics Inc. CYTX, -1.84% stock surged 7.9% to $1.78 per share in morning trade Thursday after the company said it had agreed to purchase assets from privately-held Azaya Therapeutics. Under the terms of …
Cytori Therapeutics Inc
Cytori Therapeutics, Inc. (NASDAQ:CYTX), a late stage cell therapy company developing ... M.D., Senior Vice President of Clinical Affairs, a non-qualified stock option to purchase an aggregate of 33,333 shares of the …
Cytori Therapeutics Inc (CYTX). * Cytori announces pricing of $9.5m public offering of common stock. * Says public offering of 8.60 million common shares priced at $1.10per share Source text for Eikon: Further company …